PlexusDx supports patients through ongoing monitoring and precision genetic testing via the Precision Peptide Genetic Test ($99 add-on), which identifies individual variations in peptide pathwayssuch as GLP1R rs6923761 and GIPR rs1800437to optimize compound selection and dosing strategy for each patient
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high-risk groups are provided in the full prescribing information [see Dosage and Administration (2.1 and 2.4), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), and Use in Specific Populations (8.6, 8.7)]
Technical Article
Buerlein, MD , Himesh B
This test analyzes key variants in GLP1R, GIPR, FTO, and MC4R pathways, mapping 14 biological pathways and 150+ genetic insights to refine your treatment plan
CVD prevalence has more than doubled during the last three decades, with the burden of CVD borne disproportionately by individuals with diabetes, who experience a two- to four-fold higher risk of cardiovascular events and mortality [1,2,3]